Season 1
Psychedelic Renaissance: Insights from Ethnopharmacologist Dennis McK…
In this riveting episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down with the renowned ethnopharmacologist, Dennis McKenna, to explore the profound intersection of nature, science, and healing. From Dennis’s storied...
Jason Scharf Explains How the Bio-Innovation Tech Stack Is Changing E…
In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and op...
Radiopharmaceuticals: The Future of Precision Medicine with Roger Est…
In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care. He explains the targeted nature of these therapies, th...
Decoding Digital Marketing: Insights from Aaron Burnett
In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA. He...
AI Recap - Andree Bates Episode Review
In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the h...
Mastering Omnichannel: Insights with Philip Vyt
In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Philip Vyt, a renowned expert in omnichannel strategy and founder of Shyft, a consultancy specializing in omnichannel approaches for biopharma. They delve into the key...
Staying Ahead In Your Pharma Career with Kristiaan Rawlings
In this episode, Dr. Na-Ri and Ian Wendt welcome back Kristiaan Rawlings, from EPM Scientific to discuss the latest trends in pharma and biotech hiring. They explore the key drivers of hiring, the impact of AI and advanced an...
Opioid Epidemic: Michael Barnes on the Fight to End the Crisis
In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis. They discuss the evolution of US policy on opioids, the impact of the crisis on differ...
Medical Affairs Reimagined: Danny McBryan on Shaping Pharma’s Future
Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare. He highlights the importance of medical affairs in conveying the science of pharmaceutical compa...
Empowering the Patient Voice: A Deep Dive into Advocacy with Stacey T…
In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education. They discuss the importance of patient advocacy, the role of digital health, and ...
AI Revolution: Transforming Biopharma with Andree Bates
Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advoc...
Unmasking PBMs: Antonio Ciaccia Exposes the Hidden Power Players in H…
Summary In this episode, Dr. Na-Ri Oh and Ian Wendt discuss Pharmacy Benefit Managers (PBMs) and their impact on drug pricing and patient access to medications. They are joined by Antonio Ciaccia, CEO of 46 Brooklyn Research ...
340B Controversy: Who Really Benefits from Drug Discounts?
In this episode, Dr. Na-Ri Oh and Ian Wendt discuss the 340B drug pricing program with guest William Sarraille, a healthcare law expert. They explore the origins of the program and its intended purpose. However, the program h...
From Biotech Breakthroughs to Food Tech Revolution: Dr. Ron Shigeta’s…
Summary Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest i...
From the Forest to your Pharmacy: Dr. Steven King’s Ethnobotanical Jo…
In this enlightening episode of the RealPharma Podcast, hosts Ian Wendt and Dr. Nari Oh sit down with Dr. Steven King, a luminary in the field of ethnobotanical research and sustainable pharmaceutical development. Dr. King, c...
Command the Room: Dr. Laura Sicola’s Strategies for Executive Communi…
Command the Room: Dr. Laura Sicola's Strategies for Executive Communication Excellence Hosts: Dr. Na-Ri Oh and Ian Wendt In this episode of the Real Pharma Podcast, we delve into the intricacies of effective executive communi...
Drug Importation Debate: Ilisa Bernstein on the Global Pill
Summary Ilisa Bernstein, a senior Vice President at the American Pharmacists Association, discusses the history and current landscape of drug importation policies with a focus on Florida's program. Safety concerns, supply cha...
Navigating Your Biopharma Career: A Masterclass with Recruiter Kristi…
Summary In this episode, Kristiaan Rawlings discusses the 2024-2025 Commercial Market Update and Salary Guide produced by EPM Scientific. The life sciences sector remains resilient due to aging populations, scientific advance...
Pioneering Precision: Kira Dineen on Genetics’ Role in Tailored Thera…
Summary In this episode, hosts Ian Wendt and Dr. Na-Ri Oh , and guest Kira Dineen discuss the intersection of genomics and healthcare. They explore the concept of personalized medicine and how advancements in genomics are rev...
Venture Capital & Biopharma: Jim Trenkle on Pioneering Health Innovat…
Dive into the high-stakes world of Venture Capital in biopharma with Jim Trenkle! Have you ever wondered what it takes to turn groundbreaking scientific discoveries into life-saving treatments? What role do venture capitalist...
Decoding HEOR: Iris Tam’s Insights on Pharma’s Value-Based Future
Join us on a deep dive into the world of Health Economics and Outcomes Research (HEOR) with the remarkable Iris Tam, PharmD, a luminary in value-based evidence generation within the biopharma industry. In this episode, our ho...
Redefining Fertility Care: Shelley Bailey’s Journey with Famlee
Dive into the world of fertility with Shelley Bailey, the visionary founder and CEO of Famlee Fertility, on our latest episode. Discover Shelley's personal journey that led to the creation of Famlee, a company revolutionizing...
A Surgeon General’s Perspective: Dr. Adams on Health Innovation and E…
Dr. Jerome Adams, the 20th US Surgeon General, discusses various topics related to public health, including Operation Warp Speed, diversity in clinical trials, improving healthcare access and outcomes, addressing health inequ...
Advocacy in Action: Coy Stout’s Vision for Empowered Healthcare
Trying to understand how pharma can effectively partner with patient advocates to support better patient outcomes? In this episode, Coy Stout discusses his journey in patient advocacy and the intersection of patient advocacy,...